Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Claudepierre

Showing results (41-50 of 154) with videos related to

Pageof 16
Sort By:
Joint Bone Spine|May 16, 2022
Axial psoriatic arthritis: New entity or clinical form only?Daniel Wendling, Frank Verhoeven, Pascal Claudepierre, et al.
Arthritis Research & Therapy|March 17, 2010
Effectiveness of adalimumab in treating patients with ankylosing spondylitis associated with enthesitis and peripheral arthritisMartin Rudwaleit, Pascal Claudepierre, Martina Kron, et al.
The Journal of Rheumatology|February 12, 2009
Efficacy of etanercept in lymphedema associated with psoriatic arthritisFernando Kemta Lekpa, Andra Economu-Dubosc, Claire Fevre, et al.
The Journal of Rheumatology|November 3, 2005
Infliximab to etanercept switch in patients with spondyloarthropathies and psoriatic arthritis: preliminary dataCaroline Delaunay, Valérie Farrenq, André Marini-Portugal, et al.
Annals of the Rheumatic Diseases|January 7, 2014
Evaluation of the validity of the different arms of the ASAS set of criteria for axial spondyloarthritis and description of the different imaging abnormalities suggestive of spondyloarthritis: data from the DESIR cohortAnna Moltó, Simon Paternotte, Désirée van der Heijde, et al.
Clinical and Experimental Rheumatology|January 11, 2021
High prevalence of small intestinal bacterial overgrowth (SIBO) in spondylarthropathyJean-Marie Laroche, Nathalie Kapel, Nacer Benahmed, et al.
The British Journal of Dermatology|June 30, 2022
Paradoxical reactions and biologic agents: a French cohort study of 9303 patientsPauline Bataille, Richard Layese, Pascal Claudepierre, et al.
Rheumatology (Oxford, England)|July 10, 2021
Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort studyLaura Pina Vegas, Philippe Le Corvoisier, Laetitia Penso, et al.
Presse Medicale (Paris, France : 1983)|May 8, 2010
Factors affecting students performance on the National Ranking Examination in a French Medical SchoolPascal Andujar, Sylvie Bastuji-Garin, Françoise Botterel, et al.
The Journal of Rheumatology|October 3, 2006
Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case seriesJean David Cohen, Irina Bournerias, Valérie Buffard, et al.
Pageof 16

Showing results (41-50 of 154) with videos related to

Sort By:
Pageof 16
Joint Bone Spine|May 16, 2022
Axial psoriatic arthritis: New entity or clinical form only?Daniel Wendling, Frank Verhoeven, Pascal Claudepierre, et al.
Arthritis Research & Therapy|March 17, 2010
Effectiveness of adalimumab in treating patients with ankylosing spondylitis associated with enthesitis and peripheral arthritisMartin Rudwaleit, Pascal Claudepierre, Martina Kron, et al.
The Journal of Rheumatology|February 12, 2009
Efficacy of etanercept in lymphedema associated with psoriatic arthritisFernando Kemta Lekpa, Andra Economu-Dubosc, Claire Fevre, et al.
The Journal of Rheumatology|November 3, 2005
Infliximab to etanercept switch in patients with spondyloarthropathies and psoriatic arthritis: preliminary dataCaroline Delaunay, Valérie Farrenq, André Marini-Portugal, et al.
Annals of the Rheumatic Diseases|January 7, 2014
Evaluation of the validity of the different arms of the ASAS set of criteria for axial spondyloarthritis and description of the different imaging abnormalities suggestive of spondyloarthritis: data from the DESIR cohortAnna Moltó, Simon Paternotte, Désirée van der Heijde, et al.
Clinical and Experimental Rheumatology|January 11, 2021
High prevalence of small intestinal bacterial overgrowth (SIBO) in spondylarthropathyJean-Marie Laroche, Nathalie Kapel, Nacer Benahmed, et al.
The British Journal of Dermatology|June 30, 2022
Paradoxical reactions and biologic agents: a French cohort study of 9303 patientsPauline Bataille, Richard Layese, Pascal Claudepierre, et al.
Rheumatology (Oxford, England)|July 10, 2021
Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort studyLaura Pina Vegas, Philippe Le Corvoisier, Laetitia Penso, et al.
Presse Medicale (Paris, France : 1983)|May 8, 2010
Factors affecting students performance on the National Ranking Examination in a French Medical SchoolPascal Andujar, Sylvie Bastuji-Garin, Françoise Botterel, et al.
The Journal of Rheumatology|October 3, 2006
Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case seriesJean David Cohen, Irina Bournerias, Valérie Buffard, et al.
Pageof 16